Sustaining Sponsors

Donors making a three-year commitment of $25,000-$49,999 per year. Their generous support is crucial to Keystone Symposia's ability to plan future scientific conferences focused on emerging topics and excellence in science.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org, Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.
Abide Therapeutics Inc. Arena Pharmaceuticals, Inc. Astellas Pharma Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Cell Signaling Technology, Inc. Editas Medicine
EMD Serono Research and Development Institute, Inc. Genmab A/S Gilead Sciences, Inc.
ImmunoGen, Inc. Intercept Pharmaceuticals, Inc. Juno Therapeutics
MedImmune Mersana Therapeutics Moderna Therapeutics
MorphoSys AG Nestlé Institute of Health Sciences Novartis Institutes for BioMedical Research
OncoMed Pharmaceuticals, Inc. Sangamo BioSciences, Inc. Shire Human Genetic Therapies
TESARO, Inc. Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Incorporated



Sponsors

Donors contributing $25,000-$49,999. These generous gifts allow us to convene meetings in a wide variety of important areas, many of which are in the early stages of research. Special thanks to these organizations for consistent, annual Sponsor-level support.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org, Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.
AbbVie Inc. Biogen Bristol-Myers Squibb Company
Burroughs Wellcome Fund California Institute for Regenerative Medicine (CIRM) GlaxoSmithKline
Ionis Pharmaceuticals, Inc. Janssen R&D: Pharmaceutical Companies of Johnson & Johnson Educational grant from Lilly
Sanofi US Taylor & Francis Theravance Biopharma